Gilead Sciences

• 

  Best 5 Investment Picks for 2013

  By Joyce Hanson, AdvisorOne  |  December 19, 2012

  One thing seems clear about the market's direction in 2013: Investors seeking yield–isn’t everybody nowadays–will find more joy in equities than in fixed income.

• 

  T. Rowe’s In-House Doctor Gives Healthcare Stock Picks for 2013

  By Joyce Hanson, AdvisorOne  |  November 28, 2012

  T. Rowe Price’s doctor is in–and diagnosing where the best stock picks can be found in the healthcare sector as reforms take hold next year.

• 

  Top Performing Sector ETFs of 2011

  By John Sullivan, AdvisorOne  |  December 9, 2011

  Sectors, dividends and ETFs could be the new gold, frankincense and myrrh based on performance over the past year.

• Biotech/Health Care

  By Janet Levaux, AdvisorOne  |  September 1, 2008

  Thanks to new drugs, acquisitions and other factors, biotech and health-care firms alike are forging beneficial growth and development strategies - which is good news...

• Blending In Nicely

  By Staff writer  |  November 1, 2006

  Large-cap blend funds seek to combine the best of both worlds--growth-oriented stocks which provide high earnings growth, tempered by value-oriented issues which offer the stability...

• A Time of Innovation

  By Staff writer  |  September 1, 2006

  New products and other factors drive growth in health care/biotech, despite a cautious regulatory environment, analysts say. ----- Jason Kantor RBC Capital Markets 415-633-8565 Jason.kantor@rbccm.com Outlook: Fundamentally, I don't think the...

• Interview: Tony Weber and Chuck McCurdy of ABN AMRO Veredus Select Growth Fund

  By Staff writer  |  September 30, 2005

  S&P Rank: 5 Stars Using Inefficiency to Their Advantage

• Evan McCulloch of Franklin Biotechnology Discovery Fund

  By Staff writer  |  March 24, 2004

  S&P Rank: 3 Stars March 11, 2004 Biotechs High on Drug Approvals